+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Organ-on-a-Chip: Global Markets

  • PDF Icon

    Report

  • 113 Pages
  • April 2025
  • Region: Global
  • BCC Research
  • ID: 4807360

This report analyzes trends in the global organ-on-a-chip (OoC) market. The market is segmented based on products and services, applications, end users, and regions. The application segment is characterized by drug discovery and development, toxicological research, and physiological model development. End-users include academic and research institutes, pharmaceutical and biotechnology companies, and the cosmetics industry. Products and services include organ chips, instruments, software, and services. Organ chips are further segmented into single-organ and multi-organ-on-a-chip products. The single-organ-on-a-chip products are further sub-segmented into liver, lung, heart, kidney, and other organs.

The report focuses on the major trends and challenges that affect the market and vendor landscape. It analyzes patents and emerging technologies related to the market. The report includes an analysis of the competitive landscape and industry structure and concludes with profiles of the leading companies.

In this report, the OoC market is segmented by geographical region into North America, Europe, Asia Pacific, South America, and the Middle East and Africa (MEA). The North American region consists of the U.S., Canada, and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific. The report covers global revenue ($ millions) for the base year of 2023, estimated data for 2024, and forecast values for 2025 through 2029.

Report Includes

  • 77 data tables and 53 additional tables
  • Analyses of trends in the global organ-on-a-chip (OoC) market, with revenue data for 2021 to 2023, estimates for 2024, as well as projected CAGRs through 2029
  • Estimates of the market size and revenue prospects for the global market, along with a market share analysis by product and service, application, end user and region
  • Facts and figures pertaining to the market dynamics, technological progress, innovations, prospects, regulations and the impact of various macroeconomic factors
  • A look at why organ-on-a-chip technology is gaining traction as an alternative to animal testing in life science research, toxicology testing and drug development studies
  • Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Profiles of leading companies, including Emulate Inc., Mimetas, TissUse GmbH, InSphero AG, and CN Bio Innovations Ltd.

Table of Contents

Chapter 1 Executive Summary
  • Market Outlook
  • Scope of Report
  • Market Summary
Chapter 2 Market Overview
  • Overview
  • Technology Background
  • Types of Omics
  • Technological Infrastructure and Data Integration
  • Macroeconomic Factors Analysis
  • Impact of Ongoing Russia-Ukraine War on the Single-cell Genomics and Proteomics Market
  • Economic Uncertainty and Research Funding Cuts
  • Increased Operational Costs
  • Shift in Geopolitical Collaborations
  • Sanctions on Russia and Technology Exports
  • Porter's Five Forces Analysis
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Potential of New Entrants
  • Competition in the Industry
  • Threat of Substitutes
Chapter 3 Regulatory Landscape
  • Regulatory Overview
  • Market Regulations by Country/Region
  • Federal Regulation
  • CMS Regulation
  • FDA Regulation
  • FTC Regulation
  • Canada
  • European Union
  • United Kingdom (U.K.)
  • China
  • Japan
  • Australia
  • International Standards and Guidelines
Chapter 4 Market Dynamics
  • Market Dynamics
  • Market Drivers
  • Increasing Investment and Funding for Single-cell Genomics and Proteomics Research Activities
  • Growing Prevalence of Cancer Generating Demand for Personalized Treatments
  • Promising Applications of Single-cell Genomics and Proteomics in the Drug Development Process
  • Market Restraints
  • High Costs Associated with Single-cell Proteomics
  • Technical Challenges
  • Market Opportunities
  • Technological Advances and Automation in Single-cell Studies
  • Collaboration and Partnerships
Chapter 5 Emerging Technologies and Developments
  • Artificial Intelligence in Single-cell Genomics and Proteomics
  • Companies in the AI Single-cell Genomics and Proteomics Market
  • Advances in Single-cell Omics and Multi-omics
Chapter 6 Market Segmentation Analysis
  • Market Overview
  • Segmentation Breakdown
  • Global Single-cell Genomics and Proteomics Market by Analysis Type
  • Single-cell Genomics
  • Single-cell Proteomics
  • Single-cell Transcriptomics
  • Single-cell Epigenomics
  • Global Single-cell Genomics and Proteomics Market by Application
  • Oncology
  • Stem Cell Biology
  • Immunology
  • Other Applications
  • Global Single-cell Genomics and Proteomics Market by End User
  • Academic and Research Organizations
  • Biopharmaceutical and Biotechnology Companies
  • Clinical Laboratories
  • Applied Markets
  • Geographic Breakdown
  • Global Single-cell Genomics and Proteomics Market by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Chapter 7 Competitive Intelligence
  • Overview
  • Top Players Ranking
  • Key Strategies Adopted by Players
  • Collaborations and Partnerships
  • New Product Launches
  • Expansions and Investments
  • Mergers and Acquisitions
  • Patent Analysis
  • Takeaways
Chapter 8 Sustainability in the Genomics and Proteomics Market: ESG Perspective
  • Introduction to ESG
  • ESG Performance in the Market
  • ESG Practices in the Genomics and Proteomics Industry
  • Environmental Performance
  • Social Performance
  • Governance Performance
  • ESG Risk Ratings
  • Concluding Remarks
Chapter 9 Appendix
  • Methodology
  • Abbreviations
  • Company Profiles
  • 10X GENOMICS
  • AGILENT TECHNOLOGIES INC.
  • BD
  • BIO-RAD LABORATORIES INC.
  • BIO-TECHNE
  • BRUKER
  • F. HOFFMANN-LA ROCHE LTD.
  • ILLUMINA INC.
  • MERCK KGAA
  • PROMEGA CORP.
  • QIAGEN
  • SARTORIUS AG
  • STANDARD BIOTOOLS
  • TECAN TRADING AG
  • THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table: Global Organ-on-a-Chip Market, by Region, Through 2029
Table 1: Advantages and Disadvantages of Commonly Used Materials for OoC Design
Table 2: Comparison of Organ-on-a-Chip with Traditional Drug Discovery Methods
Table 3: Raw Materials Manufacturers
Table 4: Porter’s Five Forces Analysis of the Organ-on-a-Chip Industry
Table 5: Global Organ-on-a-Chip Market, by Product and Service, Through 2029
Table 6: Global Organ Chip Market, by Organ Number, Through 2029
Table 7: Global Single-Organ-on-a-Chip Market, by Organ Chip Type, Through 2029
Table 8: Global Liver-on-a-Chip Market, by Region, Through 2029
Table 9: Global Lung-on-a-Chip Market, by Region, Through 2029
Table 10: Global Heart-on-a-Chip Market, by Region, Through 2029
Table 11: Global Kidney-on-a-Chip Market, by Region, Through 2029
Table 12: Global Other Organ Chips Market, by Region, Through 2029
Table 13: Global Multi-organ Chips Market, by Region, Through 2029
Table 14: Global Organ-on-a-Chip Devices Market, by Region, Through 2029
Table 15: Global Organ-on-a-Chip Software Market, by Region, Through 2029
Table 16: Global Organ-on-a-Chip Services Market, by Region, Through 2029
Table 17: Global Organ-on-a-Chip Services Market, by Service Type, Through 2029
Table 18: Global Organ-on-a-Chip Standard Services Market, by Region, Through 2029
Table 19: Global Organ-on-a-Chip Custom Services Market, by Region, Through 2029
Table 20: Global Organ-on-a-Chip Market, by Application, Through 2029
Table 21: Pharmaceutical Spending as a Percentage of Total Healthcare Spending, by Country, 2021
Table 22: Global Organ-on-a-Chip Market in Drug Discovery and Development, by Region, Through 2029
Table 23: Global Organ-on-a-Chip Market in Toxicological Research, by Region, Through 2029
Table 24: Global Organ-on-a-Chip Market in Physiological Model Development, by Region, Through 2029
Table 25: Global Organ-on-a-Chip Market, by End User, Through 2029
Table 26: Global Organ-on-a-Chip Market for Biotechnology and Pharmaceutical Firms, by Region, Through 2029
Table 27: Cancer Research Grants in the U.S., by Cancer Type, as of July 2024
Table 28: Global Organ-on-a-Chip Market for Academic and Research Institutes, by Region, Through 2029
Table 29: Global Organ-on-a-Chip Market for Cosmetics Companies, by Region, Through 2029
Table 30: Global Organ-on-a-Chip Market for Other End Users, by Region, Through 2029
Table 31: Global Organ-on-a-Chip Market, by Region, Through 2029
Table 32: North American Organ-on-a-Chip Market, by Country, Through 2029
Table 33: North American Organ-on-a-Chip Market, by Products and Services, Through 2029
Table 34: North American Organ Chip Market, by Organ Number, Through 2029
Table 35: North American Single-Organ-on-a-Chip Market, by Organ Chip Type, Through 2029
Table 36: North American Organ-on-a-Chip Services Market, by Service Type, Through 2029
Table 37: North American Organ-on-a-Chip Market, by Application, Through 2029
Table 38: North American Organ-on-a-Chip Market, by End User, Through 2029
Table 39: U.S. Organ-on-a-Chip Market, Through 2029
Table 40: Canadian Organ-on-a-Chip Market, Through 2029
Table 41: Mexican Organ-on-a-Chip Market, Through 2029
Table 42: Organ-on-a-Chip Initiatives in Europe
Table 43: European Organ-on-a-Chip Market, by Country, Through 2029
Table 44: European Organ-on-a-Chip Market, by Product and Service, Through 2029
Table 45: European Organ Chip Market, by Organ Number, Through 2029
Table 46: European Single-Organ-on-a-Chip Market, by Organ Chip Type, Through 2029
Table 47: European Organ-on-a-Chip Service Market, by Service Type, Through 2029
Table 48: European Organ-on-a-Chips Market, by Application, Through 2029
Table 49: European Organ-on-a-Chips Market, by End User, Through 2029
Table 50: German Organ-on-a-Chip Market, Through 2029
Table 51: French Organ-on-a-Chip Market, Through 2029
Table 52: Italian Organ-on-a-Chip Market, Through 2029
Table 53: Spanish Organ-on-a-Chip Market, Through 2029
Table 54: U.K. Organ-on-a-Chip Market, Through 2029
Table 55: Rest of European Organ-on-a-Chip Market, Through 2029
Table 56: Asia-Pacific Organ-on-a-Chip Market, by Country, Through 2029
Table 57: Asia-Pacific Organ-on-a-Chip Market, by Products and Services, Through 2029
Table 58: Asia-Pacific Organ Chip Market, by Organ Number, Through 2029
Table 59: Asia-Pacific Single-Organ-on-a-Chip Market, by Organ Chip Type, Through 2029
Table 60: Asia-Pacific Organ-on-a-Chip Service Market, by Service Type, Through 2029
Table 61: Asia-Pacific Organ-on-a-Chip Market, by Application, Through 2029
Table 62: Asia-Pacific Organ-on-a-Chip Market, by End User, Through 2029
Table 63: Chinese Organ-on-a-Chip Market, Through 2029
Table 64: Japanese Organ-on-a-Chip Market, Through 2029
Table 65: Indian Organ-on-a-Chip Market, Through 2029
Table 66: Australian Organ-on-a-Chip Market, Through 2029
Table 67: South Korean Organ-on-a-Chip Market, Through 2029
Table 68: Rest of Asia-Pacific Organ-on-a-Chip Market, Through 2029
Table 69: South American Organ-on-a-Chip Market, by Product and Service, Through 2029
Table 70: South American Organ Chip Market, by Organ Number, Through 2029
Table 71: South American Single-Organ-on-a-Chip Market, by Organ Chip Type, Through 2029
Table 72: South American Organ-on-a-Chip Services Market, by Service Type, Through 2029
Table 73: South American Organ-on-a-Chip Market, by Application, Through 2029
Table 74: South American Organ-on-a-Chip Market, by End User, Through 2029
Table 75: MEA Organ-on-a-Chip Market, by Product and Service, Through 2029
Table 76: MEA Organ Chip Market, by Organ Number, Through 2029
Table 77: MEA Single-Organ-on-a-Chip Market, by Organ Chip Type, Through 2029
Table 78: MEA Organ-on-a-Chip Service Market, by Service Type, Through 2029
Table 79: MEA Organ-on-a-Chip Market, by Application, Through 2029
Table 80: MEA Organ-on-a-Chip Market, by End User, Through 2029
Table 81: Competitive Analysis of Organ-on-a-Chip Companies, by Tier
Table 82: Strategic Alliances in the Organ-on-a-Chip Industry, 2023-2025
Table 83: M&A in the Organ-on-a-Chip Industry, 2022-2024
Table 84: Funding and Grants for Organ-on-a-Chip Companies, 2022-2024
Table 85: Patents, by Jurisdiction, 2021-2024
Table 86: Active Patents of Leading Organ-on-a-Chip Companies, 2021-2024
Table 87: Report Sources
Table 88: Abbreviations Used in this Report
Table 89: 4Dcell: Company Snapshot
Table 90: 4Dcell: Product Portfolio
Table 91: AxoSim: Company Snapshot
Table 92: AxoSim: Product Portfolio
Table 93: AxoSim: News/Key Developments, 2023
Table 94: Beonchip: Company Snapshot
Table 95: Beonchip: Product Portfolio
Table 96: BioIVT: Company Snapshot
Table 97: BioIVT: Product Portfolio
Table 98: BioIVT: News/Key Developments, 2022-2024
Table 99: BiomimX S.r.l.: Company Snapshot
Table 100: BiomimX S.r.l.: Product Portfolio
Table 101: BiomimX S.r.l.: News/Key Developments, 2021
Table 102: Cherry Biotech: Company Snapshot
Table 103: Cherry Biotech: Product Portfolio
Table 104: CN Bio Innovations Ltd.: Company Snapshot
Table 105: CN Bio Innovations Ltd.: Financial Performance, FY 2022 and 2023
Table 106: CN Bio Innovations Ltd.: Product Portfolio
Table 107: CN Bio Innovations Ltd.: News/Key Developments, 2024 and 2025
Table 108: Elveflow: Company Snapshot
Table 109: Elveflow: Product Portfolio
Table 110: Elveflow: News/Key Developments, 2024
Table 111: Emulate Inc.: Company Snapshot
Table 112: Emulate Inc.: Product Portfolio
Table 113: Emulate Inc.: News/Key Developments, 2024
Table 114: InSphero: Company Snapshot
Table 115: InSphero: Product Portfolio
Table 116: InSphero: News/Key Developments, 2023 and 2024
Table 117: Kirkstall Ltd.: Company Snapshot
Table 118: Kirkstall Ltd.: Product Portfolio
Table 119: Mimetas B.V.: Company Snapshot
Table 120: Mimetas B.V.: Product Portfolio
Table 121: Mimetas B.V.: News/Key Developments, 2023
Table 122: Quris Technologies Ltd: Company Snapshot
Table 123: Quris Technologies Ltd.: Product Portfolio
Table 124: Quris Technologies Ltd.: News/Key Developments, 2022-2024
Table 125: SynVivo Inc.: Company Snapshot
Table 126: SynVivo Inc.: Product Portfolio
Table 127: TissUse GmbH: Company Snapshot
Table 128: TissUse GmbH: Product Portfolio
Table 129: Other Key Players in the Organ-on-a-Chip Industry

List of Figures
Summary Figure: Global Organ-on-a-Chip Market Shares, by Region, 2023
Figure 1: Timeline of Organ-on-a-Chip Technology
Figure 2: Drug Development Process
Figure 3: Supply Chain of the Organ-on-a-Chip Industry
Figure 4: Organ-on-a-Chip Market Dynamics
Figure 5: Emerging Technologies in the Organ-on-a-Chip Market
Figure 6: Global Organ-on-a-Chip Market Shares, by Product and Service, 2023
Figure 7: Global Single-Organ-on-a-Chip Market Shares, by Organ Chip Type, 2023
Figure 8: Global Organ-on-a-Chip Market Shares, by Application, 2023
Figure 9: Global Organ-on-a-Chip Market Shares, by End User, 2023
Figure 10: Global Organ-on-a-Chip Market Shares, by Region, 2023
Figure 11: North American Organ-on-a-Chip Market Shares, by Country, 2023
Figure 12: European Organ-on-a-Chip Market Shares, by Country, 2023
Figure 13: Asia-Pacific Organ-on-a-Chip Market Shares, by Country, 2023
Figure 14: CN Bio Innovations Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 15: CN Bio Innovations Ltd.: Revenue Shares, by Country/Region, FY 2023

Samples

Loading
LOADING...

Companies Mentioned

  • 10X GENOMICS
  • AGILENT TECHNOLOGIES INC.
  • BD
  • BIO-RAD LABORATORIES INC.
  • BIO-TECHNE
  • BRUKER
  • F. HOFFMANN-LA ROCHE LTD.
  • ILLUMINA INC.
  • MERCK KGAA
  • PROMEGA CORP.
  • QIAGEN
  • SARTORIUS AG
  • STANDARD BIOTOOLS
  • TECAN TRADING AG
  • THERMO FISHER SCIENTIFIC INC.

Table Information